Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | DPP4 | P27487 | 4/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.36 |
| ▸ | NAAA | Q02083 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TPSAB1 | Q15661 | 5/20 | 0.33 |
| ▸ | TPSD1 | Q9BZJ3 | 5/20 | 0.33 |
| ▸ | TPSG1 | Q9NRR2 | 5/20 | 0.33 |
| ▸ | FAP | Q12884 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15574877 | 1.00 | CYP19A1 (0.44) | CYP19A1EPHX1DPP4DPP7NAAA | |
| SCHEMBL18378683 | 1.00 | CYP19A1 (0.44) | CYP19A1EPHX1DPP4DPP7NAAA | |
| Hydrochloric Acid SCHEMBL18492024 | 0.98 | CYP19A1 (0.42) | CYP19A1EPHX1DPP4DPP7NAAA | |
| Hydrochloric Acid SCHEMBL215574 | 0.98 | CYP19A1 (0.42) | CYP19A1EPHX1DPP4DPP7NAAA | |
| Hydrochloric Acid SCHEMBL5285959 | 0.98 | CYP19A1 (0.42) | CYP19A1EPHX1DPP4DPP7NAAA | |
| SCHEMBL159982 | 0.96 | CYP19A1 (0.47) | CYP19A1EPHX1DPP4DPP7NAAA | |
| SCHEMBL13543466 | 0.96 | CYP19A1 (0.47) | CYP19A1EPHX1DPP4DPP7NAAA | |
| SCHEMBL723290 | 0.96 | CYP19A1 (0.47) | CYP19A1EPHX1DPP4DPP7NAAA | |
| SCHEMBL770738 | 0.94 | CYP19A1 (0.50) | CYP19A1EPHX1NAAAL3MBTL1HTT | |
| SCHEMBL16373577 | 0.94 | CYP19A1 (0.50) | CYP19A1EPHX1NAAAL3MBTL1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250034211-A1 | C-TERMINAL EXTENDED P53 ACTIVATOR CROSSLINKED PEPTIDOMIMETIC MACROCYCLES AGAINST MDM2/MDMX | MERCK SHARP & DOHME LLC (US) | 2025-01-30 | — | — | US | claimed |
| EP-4441067-A1 | C-TERMINAL EXTENDED P53 ACTIVATOR CROSSLINKED PEPTIDOMIMETIC MACROCYCLES AGAINST MDM2/MDMX | Merck Sharp & Dohme LLC (US) | 2024-10-09 | — | — | EP | claimed |
| US-20230192789-A1 | STRUCTURALLY-STABILIZED AND HDMX-SELECTIVE P53 PEPTIDES AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | 2023-06-22 | — | — | US | claimed |
| WO-2023096947-A1 | C-TERMINAL EXTENDED P53 ACTIVATOR CROSSLINKED PEPTIDOMIMETIC MACROCYCLES AGAINST MDM2/MDMX | MERCK SHARP & DOHME LLC (US) | 2023-06-01 | — | — | WO | claimed |
| EP-4142766-A2 | STRUCTURALLY-STABILIZED AND HDMX-SELECTIVE P53 PEPTIDES AND USES THEREOF | Dana Farber Cancer Institute, Inc. (US) | 2023-03-08 | — | — | EP | claimed |
| US-20220168383-A1 | NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2022-06-02 | — | — | US | claimed |
| WO-2021222243-A2 | STRUCTURALLY-STABILIZED AND HDMX-SELECTIVE P53 PEPTIDES AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2021-11-04 | — | — | WO | claimed |
| EP-3412677-A1 | CYCLOBUTYL (S)-2-[[[(R)-2-(6-AMINOPURIN-9-YL)-1-METHYL-ETHOXY]METHYL-PHENOXY-PHOSPHORYL]AMINO]-PROPANOATES, AND METHOD FOR PRODUCING AND USING SAME | Alla Chem, LLC (US) | 2018-12-12 | — | — | EP | claimed |
| CN-107849071-A | antiviral β amino acid ester phosphorodiamidate compounds | 默沙东公司 | 2018-03-27 | — | — | CN | claimed |
| CN-107592865-A | Peptidomimetic compounds for neutralizing influenza viruses | 扬森疫苗与预防公司 | 2018-01-16 | — | — | CN | claimed |
| US-7078384-B2 | Mimetic insect allatostatin analogs for insect control | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2006-07-18 | — | — | US | claimed |
| US-20040229812-A1 | Mimetic insect allatostatin analogs for insect control | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2004-11-18 | — | — | US | claimed |
| US-20040039159-A1 | Mimetic insect allatostatin analogs for insect control | NACHMAN RONALD J (US) | 2004-02-26 | — | — | US | claimed |
| US-20030161857-A1 | Mimetic insect allatostatin analogs for insect control | UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2003-08-28 | — | — | US | claimed |
| US-6207643-B1 | PSEUDOPEPTIDE ANALOGS ARE PRODUCED WHICH EXHIBIT AN OVERALL AMPHIPHILIC NATURE AND WHICH ARE CAPABLE OF PENETRATING THE INSECT CUTICLE WHILE STILL RETAINING BIOLOGICAL ACTIVITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2001-03-27 | — | — | US | claimed |
| WO-2000029010-A1 | MIMETIC INSECT ALLATOSTATIN ANALOGS FOR INSECT CONTROL | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2000-05-25 | — | — | WO | claimed |
| US-20260109724-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4107164-B1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-12-03 | — | — | EP | disclosed |
| US-6207643-B1 | PSEUDOPEPTIDE ANALOGS ARE PRODUCED WHICH EXHIBIT AN OVERALL AMPHIPHILIC NATURE AND WHICH ARE CAPABLE OF PENETRATING THE INSECT CUTICLE WHILE STILL RETAINING BIOLOGICAL ACTIVITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2001-03-27 | — | — | US | disclosed |
| WO-2000029010-A1 | MIMETIC INSECT ALLATOSTATIN ANALOGS FOR INSECT CONTROL | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2000-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109724-A1 | ANTIVIRAL COMPOUNDS | IRF3, IFNAR1, HAVCR2 | CYP19A1 3722/4885EPHX1 1627/4885DPP4 65/4885 |
| US-20230192789-A1 | STRUCTURALLY-STABILIZED AND HDMX-SELECTIVE P53 PEPTIDES AND USES THEREOF | TP53, TP53BP1, MDM2 | CYP19A1 4026/4885EPHX1 2118/4885DPP4 1515/4885 |
| US-20040039159-A1 | Mimetic insect allatostatin analogs for insect control | ANPEP, CTRL, DNPEP | CYP19A1 1128/4885EPHX1 4677/4885DPP4 213/4885 |
| US-20030161857-A1 | Mimetic insect allatostatin analogs for insect control | ANPEP, CTRL, DNPEP | CYP19A1 1128/4885EPHX1 4677/4885DPP4 213/4885 |
| US-20040229812-A1 | Mimetic insect allatostatin analogs for insect control | ANPEP, CTRL, DNPEP | CYP19A1 1128/4885EPHX1 4677/4885DPP4 213/4885 |
| US-20250034211-A1 | C-TERMINAL EXTENDED P53 ACTIVATOR CROSSLINKED PEPTIDOMIMETIC MACROCYCLES AGAINST MDM2/MDMX | TP53, MDM4, MDM2 | CYP19A1 2614/4885EPHX1 3565/4885DPP4 187/4885 |
| US-20220168383-A1 | NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN | VIP, NTSR2, VIPR2 | CYP19A1 1466/4885EPHX1 1524/4885DPP4 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.